A large-scale randomized European trial of low-dose CT lung cancer screening yielded a nodule rate of 18% but a cancer detection rate of 0.8%, according to a presentation at the ECR on Friday. A separate study based on the same group underscored the importance of accurately identifying nodule growth rate.
A large-scale randomized European trial of low-dose CT lung cancer screening yielded a nodule rate of 18% but a cancer detection rate of 0.8%, according to a presentation at the ECR on Friday. A separate study based on the same group underscored the importance of accurately identifying nodule growth rate.
The trial was conducted by researchers at three institutions (Groningen, Rotterdam, and Utrecht), with a sample of more than 15,000 participants who were current or former smokers. Participants were randomized into two groups: one was scanned with low-dose 16-slice CT and the other served as a control.
Data from April 2004 through December 2005 were included in the screening study, with a total of 5700 patients screened. A total 1026 patients (18%) were found to have nodules. Of these nodules, 912 were deemed significant and 114 were deemed potentially malignant. Forty-six (0.8%) were found to be lung cancer.
The study is continuing and researchers hope to accumulate a screening population of 8000, said presenter Dr. Y. Wang of Groningen.
Another study involving the same group of participants analyzed nodule growth rates of 453 indeterminate solid nodules over three months to identify which were most likely to grow and proceed to cancer. It found that the chance that fissure- and vessel-attached nodules will grow within three months is less than 8%.
Identifying which lung nodules are most likely to grow has become more important as more nodules are identified on multislice CT scans, said Dr. Donming Xu of Groningen.
Using screening scans of 3881 patients obtained between April 2004 and September 2005, researchers identified 453 indeterminate solid nodules in 331 patients. Twenty percent were fissure-attached, 15% were pleural-based, and 18% were vessel-attached. Eighteen percent of the nodules did not show typical morphological features and 29% were solitary pulmonary nodules. Only 3% of the indeterminate nodules found at baseline had grown more than 25% after three months.
The researchers concluded that focal opacity and solitary pulmonary nodules have the highest possibility of growth, but that pleural-based indeterminate nodules usually do not grow within three months.
Can Photon-Counting CT be an Alternative to MRI for Assessing Liver Fat Fraction?
March 21st 2025Photon-counting CT fat fraction evaluation offered a maximum sensitivity of 81 percent for detecting steatosis and had a 91 percent ICC agreement with MRI proton density fat fraction assessment, according to new prospective research.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Strategies to Reduce Disparities in Interventional Radiology Care
March 19th 2025In order to help address the geographic, racial, and socioeconomic barriers that limit patient access to interventional radiology (IR) care, these authors recommend a variety of measures ranging from increased patient and physician awareness of IR to mobile IR clinics and improved understanding of social determinants of health.
AI-Initiated Recalls After Screening Mammography Demonstrate Higher PPV for Breast Cancer
March 18th 2025While recalls initiated by one of two reviewing radiologists after screening mammography were nearly 10 percent higher than recalls initiated by an AI software, the AI-initiated recalls had an 85 percent higher positive predictive value for breast cancer, according to a new study.